Published by Iain Gilbert on 27th February 2024
(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,960.0p to 2,000.0p on Tuesday, citing more stability in its generics unit.
URL: http://www.digitallook.com/dl/news/story/34116862/...